Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide. [electronic resource]
- AIDS (London, England) Jun 2008
- 1232-4 p. digital
Publication Type: Case Reports; Letter
1473-5571
10.1097/QAD.0b013e3282fa75ce doi
Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Murine-Derived Castleman Disease--complications HIV Infections--complications Humans Immunologic Factors--therapeutic use Immunosuppressive Agents--therapeutic use Male Middle Aged Rituximab Thalidomide--therapeutic use